scholarly journals Correction: Enhancing Interferon Regulatory Factor 7 Mediated Antiviral Responses and Decreasing Nuclear Factor Kappa B Expression Limit HIV-1 Replication in Cervical Tissues

PLoS ONE ◽  
2015 ◽  
Vol 10 (7) ◽  
pp. e0133815
Author(s):  
PLoS ONE ◽  
2015 ◽  
Vol 10 (6) ◽  
pp. e0131919 ◽  
Author(s):  
Christiane Rollenhage ◽  
Sherrill L. Macura ◽  
Melissa J. Lathrop ◽  
Todd A. Mackenzie ◽  
Gustavo F. Doncel ◽  
...  

2012 ◽  
Vol 23 (4-5) ◽  
pp. 255-270 ◽  
Author(s):  
Giulia Marsili ◽  
Anna Lisa Remoli ◽  
Marco Sgarbanti ◽  
Edvige Perrotti ◽  
Alessandra Fragale ◽  
...  

PLoS ONE ◽  
2011 ◽  
Vol 6 (6) ◽  
pp. e21261 ◽  
Author(s):  
Ankit Shah ◽  
Ashish S. Verma ◽  
Kalpeshkumar H. Patel ◽  
Richard Noel ◽  
Vanessa Rivera-Amill ◽  
...  

AIDS ◽  
2011 ◽  
Vol 25 (5) ◽  
pp. 715-717 ◽  
Author(s):  
Judy Chang ◽  
Robert J Lindsay ◽  
Smita Kulkarni ◽  
Jeffrey D Lifson ◽  
Mary Carrington ◽  
...  

1992 ◽  
Vol 175 (5) ◽  
pp. 1181-1194 ◽  
Author(s):  
R Schreck ◽  
B Meier ◽  
D N Männel ◽  
W Dröge ◽  
P A Baeuerle

Dithiocarbamates and iron chelators were recently considered for the treatment of AIDS and neurodegenerative diseases. In this study, we show that dithiocarbamates and metal chelators can potently block the activation of nuclear factor kappa B (NF-kappa B), a transcription factor involved in human immunodeficiency virus type 1 (HIV-1) expression, signaling, and immediate early gene activation during inflammatory processes. Using cell cultures, the pyrrolidine derivative of dithiocarbamate (PDTC) was investigated in detail. Micromolar amounts of PDTC reversibly suppressed the release of the inhibitory subunit I kappa B from the latent cytoplasmic form of NF-kappa B in cells treated with phorbol ester, interleukin 1, and tumor necrosis factor alpha. Other DNA binding activities and the induction of AP-1 by phorbol ester were not affected. The antioxidant PDTC also blocked the activation of NF-kappa B by bacterial lipopolysaccharide (LPS), suggesting a role of oxygen radicals in the intracellular signaling of LPS. This idea was supported by demonstrating that treatment of pre-B and B cells with LPS induced the production of O2- and H2O2. PDTC prevented specifically the kappa B-dependent transactivation of reporter genes under the control of the HIV-1 long terminal repeat and simian virus 40 enhancer. The results from this study lend further support to the idea that oxygen radicals play an important role in the activation of NF-kappa B and HIV-1.


2005 ◽  
Vol 79 (15) ◽  
pp. 10040-10052 ◽  
Author(s):  
Angela M. Hahn ◽  
Leslie E. Huye ◽  
Shunbin Ning ◽  
Jennifer Webster-Cyriaque ◽  
Joseph S. Pagano

ABSTRACT Virus infection stimulates potent antiviral responses; specifically, Epstein-Barr virus (EBV) infection induces and activates interferon regulatory factor 7 (IRF-7), which is essential for production of alpha/beta interferons (IFN-α/β) and upregulates expression of Tap-2. Here we present evidence that during cytolytic viral replication the immediate-early EBV protein BZLF-1 counteracts effects of IRF-7 that are central to host antiviral responses. We initiated these studies by examining IRF-7 protein expression in vivo in lesions of hairy leukoplakia (HLP) in which there is abundant EBV replication but the expected inflammatory infiltrate is absent. This absence might predict that factors involved in the antiviral response are absent or inactive. First, we detected significant levels of IRF-7 in the nucleus, as well as in the cytoplasm, of cells in HLP lesions. IRF-7 activity in cell lines during cytolytic viral replication was examined by assay of the IRF-7-responsive promoters, IFN-α4, IFN-β, and Tap-2, as well as of an IFN-stimulated response element (ISRE)-containing reporter construct. These reporter constructs showed consistent reduction of activity during lytic replication. Both endogenous and transiently expressed IRF-7 and EBV BZLF-1 proteins physically associate in cell culture, although BZLF-1 had no effect on the nuclear localization of IRF-7. However, IRF-7-dependent activity of the IFN-α4, IFN-β, and Tap-2 promoters, as well as an ISRE promoter construct, was inhibited by BZLF-1. This inhibition occurred in the absence of other EBV proteins and was independent of IFN signaling. Expression of BZLF-1 also inhibited activation of IRF-7 by double-stranded RNA, as well as the activity of a constitutively active mutant form of IRF-7. Negative regulation of IRF-7 by BZLF-1 required the activation domain but not the DNA-binding domain of BZLF-1. Thus, EBV may subvert cellular antiviral responses and immune detection by blocking the activation of IFN-α4, IFN-β, and Tap-2 by IRF-7 through the medium of BZLF-1 as a negative regulator.


Sign in / Sign up

Export Citation Format

Share Document